Surprisingly enough 41 people claim that they do know someone with bipolar disorder. The other 17 individuals said no or I don’t know. It amazes me how all of these people do know someone with bipolar disorder. A total of 70.69 % of the people who answered my survey are very familiar with the disorder because of the fact that they personal know someone who has this illness. For years I have believed that bipolar disorder was so rare that it would be considered a miracle if you knew someone with this mental illness.
Discuss issues surrounding the classification and diagnosis of schizophrenia. There are two different classification systems in place to diagnose schizophrenia, the ICD-10 and the DCM. The key difference between the two classification systems is that the DCM measures symptoms over the course of 6 months, whereas the ICD-10 measures them over only one month. This poses a question of reliability, as there is a great lack of consistency between the two systems. Beck et al (1961) looked at inter-rater reliability between 2 psychiatrists who both looked at the same 154 patients, and found that the inter-rater reliability was low at 54%, meaning that the two systems may produce different results when it comes to the classification of schizophrenia.
Critical Point 3: There is a flaw with one of the key pieces of evidence to support the dopamine hypothesis. The drugs used to treat schizophrenia by blocking the dopamine receptors can actually increases it as neurons struggle to compensate for the sudden deficiency. Haracz, in a review of post-mortem studies of schizophrenics, found that most of those studied who showed elevated dopamine levels had received antipsychotic drugs shortly before death, unlike post-mortem of schizophrenics who hadn’t received medication these results showed that these individuals had normal levels of dopamine. Therefore, this evidence weakens the support for the dopamine
Torrey (2009) confirms that 70 percent of patients with Schizophrenia, who have taken these Antipsychotic Medications, have vastly improved according to studies. This means that an individual who is dealing with Schizophrenia can find a place of stability and safety on the road to recovery. To further strengthen the belief that Antipsychotic Medications are a help to individuals with Schizophrenia Torrey (2009) believes that when individuals attend therapy on a regular basis, and he or she continues their treatment of Antipsychotic Medications there will be a reduction in the symptoms of the disease, hospital stays will be shortened to almost non-existence, and the chance of acquiring to be re-hospitalized is reduced dramatically. All of these factors working together show the world at large that there is a sign of hope for individuals, which have been diagnosed with
The use of ECT declined until the 1980s, "when use began to increase amid growing awareness of its benefits and cost-effectiveness for treating severe depression". In 1985 the National Institute of Mental Health and National Institutes of Health convened a consensus development conference on ECT and concluded that, while ECT was the most controversial treatment in psychiatry and had significant side-effects, it had been shown to be effective for a narrow range of severe psychiatric disorders. Due to the backlash noted previously, national institutions reviewed past practices and set new standards. This report emphasised the importance of informed consent, and the expanded role that the procedure has in modern medicine. In 2003, The UK ECT Review group published a systematic review and meta-analysis comparing ECT to placebo and antidepressant drugs.
The reliability of the diagnosis of schizophrenia is bases on the extent to which different psychiatrists can agree on the same diagnosis of a patient and the validity is based on the extent to which psychiatrists can agree on what (the diagnosis of) schizophrenia actually is. The existence of classification systems such as the DSM or ICD claim to lead to a greater agreement on the diagnosis of schizophrenia. The different classification systems are each used in different cultures: ICD in the UK and DSM in the US. However the use of different systems of classification has problems because even though (theoretically) they both show diagnosis of SZ, they both describe schizophrenia in different ways. This is shown in a follow up study of Whaley’s inter rater reliability correlation of +.11, by Copeland et al.
From an evaluation of the report card only, Bluegrass Hospital seems to be deficient in which areas? A make believe two hundred bed facility. In which the rates are lower than the national average in areas such as Volume, but reverse in Mortality rate where most of the rates seem above the national average. Since the report is based on an evaluation of administrative data, what should the first course of action be? Herein, Fleming has made some very strong and important recommendations on how to evaluate administrative data within the text, the example made is, “The team compares the data to other internal sources of this information.
“Suspected diabetes” would be a better term, however, because the single test used by the CDC may be wildly unreliable. In 2001 a French study of 5,400 men reported that 42 percent of the men who tested positive for diabetes using the CDC method turned out to be nondiabetic when checked by a “gold standard”
Paranoid schizophrenia, what must the nurse assess? How do they go about assessing? Upon assessing, how will the nurse manage the outcomes of the assessment? These important questions are what this paper will resolve. Through review of recent literature into the assessment and management of individuals affected by paranoid schizophrenia, this paper will discuss in detail how the nurse goes about assessing the patient, why assessment is vital, common outcomes of the assessment and finally go into detail on how the nurse manages a patient with paranoid schizophrenia.
In a 2002 survey by the Depression and Bipolar Support Alliance, 70 percent of bipolar people said their doctors misdiagnosed them at least once, most often with depression or schizophrenia. If diagnosis is reliable then different practitioners should reach the same conclusions when faced with a person presenting a specific set of symptoms. This is known as inter-rater reliability. Another way of assessing reliability is for the same patient to be tested and then rested by the same practitioner; again they should get the same diagnosis for the system to be reliable (test-retest).